Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra) [India], April 10: Roche Diagnostics India announces the launch of its point-of-care NT-proBNP test for screening diabetes patients who are at risk of cardiovascular diseases (CVD) such as heart failure (HF). This breakthrough innovation is designed to bring testing closer to clinics and revolutionise patient care. The claim extension of the NT-proBNP biomarker, available exclusively on the cobas® h 232 system, aims to provide faster, more efficient diagnosis and management of HF in patients with type 2 diabetes (T2D). Business News | Roche Diagnostics India's Heart Failure Test for Diabetics Now Available on Its Point-of-care Device.